Insider Trading Alert - GFN, SCOR And SUPN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 15, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $428.00 to $1,771,500.00.

Highlighted Stocks Traded by Insiders:

General Finance (GFN) - FREE Research Report

Harris Susan L, who is Director at General Finance, bought 2,000 shares at $5.53 on June 15, 2015. Following this transaction, the Director owned 12,633 shares meaning that the stake was boosted by 18.81% with the 2,000-share transaction.

The shares most recently traded at $5.50, down $0.03, or 0.5% since the insider transaction. Historical insider transactions for General Finance go as follows:

  • 4-Week # shares bought: 26,375
  • 4-Week # shares sold: 4,878
  • 12-Week # shares bought: 26,375
  • 12-Week # shares sold: 4,878
  • 24-Week # shares bought: 26,375
  • 24-Week # shares sold: 4,878

The average volume for General Finance has been 49,200 shares per day over the past 30 days. General Finance has a market cap of $143.4 million and is part of the services sector and diversified services industry. Shares are down 44.73% year-to-date as of the close of trading on Monday.

General Finance Corporation, through its subsidiaries, leases and sells portable storage containers, portable container buildings, and freight containers. The company has a P/E ratio of 277.0. Currently, there are 2 analysts who rate General Finance a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GFN - FREE

TheStreet Quant Ratings rates General Finance as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and generally higher debt management risk. Get the full General Finance Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

comScore (SCOR) - FREE Research Report

Fulgoni Gian, who is Chairman Emeritus at comScore, sold 900 shares at $58.00 on June 15, 2015. Following this transaction, the Chairman Emeritus owned 151,890 shares meaning that the stake was reduced by 0.59% with the 900-share transaction.

The shares most recently traded at $53.93, down $4.07, or 7.55% since the insider transaction. Historical insider transactions for comScore go as follows:

  • 4-Week # shares sold: 25,200
  • 12-Week # shares sold: 139,711
  • 24-Week # shares sold: 252,219

The average volume for comScore has been 262,700 shares per day over the past 30 days. comScore has a market cap of $2.3 billion and is part of the services sector and diversified services industry. Shares are up 24.14% year-to-date as of the close of trading on Monday.

comScore, Inc. provides digital media analytics products and services for content publishers, advertisers, advertising agencies, and network operators primarily in the United States, Canada, Europe, Latin America, and Asia. Currently, there are 5 analysts who rate comScore a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCOR - FREE

TheStreet Quant Ratings rates comScore as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full comScore Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Supernus Pharmaceuticals (SUPN) - FREE Research Report

Schwabe Stefan K.F., who is Executive Vice President R&D at Supernus Pharmaceuticals, sold 2,051 shares at $18.27 on June 15, 2015. Following this transaction, the Executive Vice President R&D owned 2,794 shares meaning that the stake was reduced by 42.33% with the 2,051-share transaction.

The shares most recently traded at $16.97, down $1.30, or 7.66% since the insider transaction. Historical insider transactions for Supernus Pharmaceuticals go as follows:

  • 4-Week # shares sold: 3,631
  • 12-Week # shares sold: 3,631
  • 24-Week # shares sold: 3,631

The average volume for Supernus Pharmaceuticals has been 907,300 shares per day over the past 30 days. Supernus Pharmaceuticals has a market cap of $864.5 million and is part of the health care sector and drugs industry. Shares are up 121.33% year-to-date as of the close of trading on Monday.

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. The company has a P/E ratio of 25.1. Currently, there are 5 analysts who rate Supernus Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SUPN - FREE

TheStreet Quant Ratings rates Supernus Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. Get the full Supernus Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers